We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Sector Composition

Rank Sector Weight
1 Technology 26.99%
2 Healthcare 10.86%
3 Consumer Discretionary 10.71%
4 Financials 8.62%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIBBU
6001
DELISTED
AIB Acquisition Corp Unit
AIBBU
$1K ﹤0.01%
99
MBTCU
6002
DELISTED
Nocturne Acquisition Corporation Unit
MBTCU
$1K ﹤0.01%
+119
New +$1.22K
RCACU
6003
DELISTED
Revelstone Capital Acquisition Corp. Unit
RCACU
$1K ﹤0.01%
120
OPA.U
6004
DELISTED
Magnum Opus Acquisition Limited Units, each consisting of one Class A ordinary share and one-half redeemable warrant
OPA.U
$1K ﹤0.01%
100
PTOCU
6005
DELISTED
Pine TechnologYES Acquisition Corp. Unit
PTOCU
$1K ﹤0.01%
74
NTP
6006
DELISTED
Nam Tai Property Inc.
NTP
$1K ﹤0.01%
636
+247
+63% +$388
PMGMU
6007
DELISTED
Priveterra Acquisition Corp. II Unit
PMGMU
$1K ﹤0.01%
98
GDEV
6008
DELISTED
Nexters Inc. Ordinary Shares
GDEV
$1K ﹤0.01%
600
AACG
6009
ATA Creativity
AACG
$38.2M
$0 ﹤0.01%
260
-1,023
-80% -$1.9K
AAOI icon
6010
Applied Optoelectronics
AAOI
$11.3B
-3,354
Closed -$5K
AAPU icon
6011
Direxion Daily AAPL Bull 2X ETF
AAPU
$189M
$0 ﹤0.01%
+6
New +$142
ABX
6012
Abacus Global Management
ABX
$885M
$0 ﹤0.01%
47
-53
-53% -$532
ACTG icon
6013
Acacia Research
ACTG
$456M
-2,946
Closed -$15K
ADAG
6014
Adagene
ADAG
$259M
-3,627
Closed -$7K
ZNB
6015
Zeta Network Group
ZNB
$2.55M
0
-$9K
ADIL
6016
Adial Pharmaceuticals
ADIL
$9.24M
-11
Closed -$9K
ADVWW
6017
DELISTED
Advantage Solutions Warrant
ADVWW
$0 ﹤0.01%
23
ADXN
6018
Addex Therapeutics
ADXN
$7.53M
$0 ﹤0.01%
+6
New +$134
AFRIW icon
6019
Forafric Global PLC Warrants
AFRIW
$10.8M
$0 ﹤0.01%
94
AGMH icon
6020
AGM Group Holdings
AGMH
$2.48M
-78
Closed -$5K
AVX
6021
Avax One Technology Ltd
AVX
$26.1M
0
AGRO icon
6022
Adecoagro
AGRO
$1.38B
$0 ﹤0.01%
+53
New +$445
AIA icon
6023
iShares Asia 50 ETF
AIA
$4.96B
-846
Closed -$53K
AIRT icon
6024
Air T
AIRT
$82.8M
-697
Closed -$11K
AKO.A icon
6025
Embotelladora Andina Series A
AKO.A
$3.63B
-300
Closed -$3K

Similar funds

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.